Resource Library

Our resource library is designed to help healthcare professionals keep up to date on the latest Unicycive product posters and presentations. We’re always adding to the collection, so be sure to check back regularly.

Elsevier: Two-Way Randomized Crossover Study to Establish Pharmacodynamic Bioequivalence Between Oxylanthanum Carbonate and Lanthanum Carbonate

ASN ’24 OLC-201-Tolerability-Late-Breaking-Poster

ASN ’24 OLC+Tenapanor Combo Study in Rat Poster

ASN’24-UNI-494 Phase 1

ASN ’24 UNI-494 -Rat IR study Therapeutic

Pharmaceutical Chemistry Journal: Systemic Absorption of Oxylanthanum Carbonate is Minimal in Preclinical Models

EC Pharmacology and Toxicology: Evaluation of UNI-494 in Acute Kidney Injury Treatment Efficacy When Administered After Ischemia-Reperfusion in a Rat ModelEC Pharmacology and Toxicology

ERA ’24 UNI-494 IR Preventative Poster

ERA OLC Tenapanor vs OLC Study in Rat

ERA Phase 1 Tip-Focused Oral

OLC Tolerability in CKD TiP

NKF24 OLC BE Study

NKF24 – OLC Dietitian Survey

UNI-494 Phase 1 Trial in Progress – CRRT 2024

UNI-494 AKI_IR Preclinical Study – CRRT 2024

RPS: Novel phosphate binder oxylanthanum carbonate effectively reduced serum and urine phosphorus concentrations in animal models

AJN: High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders

Oxylanthanum Carbonate (OLC) Sevelamer In-Vivo Phosphate Reduction Study

Oxylanthanum Carbonate (OLC) Phosphate Binders Daily Medication Volume Poster

UNI-494 DOG 28-Day Oral Toxicity Study